pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-SOU-2024-00101 | South Africa | 2,024 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Well differentiated | Not documented | Absent | Negative | Negative | Negative | Positive | 36.3 | Negative | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-ETH-2021-00102 | Ethiopia | 2,021 | National referral | Breast | 8140/3 | Adenocarcinoma | Well differentiated | Present | Absent | Negative | Positive | Positive | Negative | 7.0 | Negative | Luminal B | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-UGA-2024-00103 | Uganda | 2,024 | National referral | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Negative | Negative | 15.5 | Not done | null | Resection | Yes | 25 | moderate_burden |
PATH-TAN-2022-00104 | Tanzania | 2,022 | District | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Absent | Close | Negative | Negative | Negative | Not done | Negative | null | Resection | Yes | 21 | moderate_burden |
PATH-ETH-2019-00105 | Ethiopia | 2,019 | Regional | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-TAN-2025-00106 | Tanzania | 2,025 | District | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Absent | Close | Positive | Negative | Positive | 68.2 | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-SOU-2018-00107 | South Africa | 2,018 | National referral | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | 57.9 | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-TAN-2022-00108 | Tanzania | 2,022 | Regional | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Not done | Not done | 84.4 | Negative | null | Excisional biopsy | Yes | 3 | moderate_burden |
PATH-KEN-2018-00109 | Kenya | 2,018 | National referral | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Not done | 80.3 | Not done | Luminal A | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-SOU-2023-00110 | South Africa | 2,023 | Regional | Bladder | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Negative | Not done | Positive | Negative | Not done | Positive | null | Resection | Yes | 18 | moderate_burden |
PATH-UGA-2019-00111 | Uganda | 2,019 | Regional | Ovary | 8510/3 | Medullary carcinoma | Poorly differentiated | Present | Present | Positive | Negative | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-NIG-2018-00112 | Nigeria | 2,018 | District | Cervix | 8720/3 | Melanoma | Moderately differentiated | Absent | Absent | Positive | Positive | Negative | Positive | Not done | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-KEN-2025-00113 | Kenya | 2,025 | Regional | Ovary | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | 43.1 | Negative | null | Core needle biopsy | No - suboptimal | 13 | moderate_burden |
PATH-UGA-2021-00114 | Uganda | 2,021 | Regional | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | 37.6 | Negative | null | Excisional biopsy | No - inconclusive | 11 | moderate_burden |
PATH-GHA-2024-00115 | Ghana | 2,024 | National referral | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Not done | Negative | 5.5 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-KEN-2022-00116 | Kenya | 2,022 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 77.2 | Not done | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-GHA-2020-00117 | Ghana | 2,020 | Regional | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Positive | Negative | Negative | Negative | 26.8 | Positive | null | Resection | No - inconclusive | 10 | moderate_burden |
PATH-TAN-2018-00118 | Tanzania | 2,018 | District | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Positive | Negative | Positive | 27.4 | Negative | null | Excisional biopsy | Yes | 12 | moderate_burden |
PATH-NIG-2025-00119 | Nigeria | 2,025 | District | Bladder | 8260/3 | Papillary carcinoma | Poorly differentiated | Present | Absent | Positive | Not done | Positive | Negative | 14.4 | Positive | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-GHA-2024-00120 | Ghana | 2,024 | District | Liver | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Absent | Close | Positive | Positive | Negative | 47.2 | Negative | null | Excisional biopsy | No - inconclusive | 7 | moderate_burden |
PATH-ETH-2022-00121 | Ethiopia | 2,022 | Regional | Stomach | 8510/3 | Medullary carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Not done | Negative | 55.0 | Negative | null | Resection | Yes | 21 | moderate_burden |
PATH-ETH-2021-00122 | Ethiopia | 2,021 | District | Liver | 8510/3 | Medullary carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Positive | Not done | Negative | null | Resection | Yes | 21 | moderate_burden |
PATH-ETH-2020-00123 | Ethiopia | 2,020 | National referral | Stomach | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 68.1 | Negative | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-KEN-2024-00124 | Kenya | 2,024 | District | Prostate | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Negative | Negative | Not done | Negative | null | Excisional biopsy | No - suboptimal | 19 | moderate_burden |
PATH-UGA-2019-00125 | Uganda | 2,019 | National referral | Ovary | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 9.0 | Positive | null | Resection | No - inconclusive | 4 | moderate_burden |
PATH-GHA-2020-00126 | Ghana | 2,020 | Regional | Bladder | 8260/3 | Papillary carcinoma | Moderately differentiated | Present | Present | Close | Positive | Negative | Negative | 9.9 | Negative | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-KEN-2023-00127 | Kenya | 2,023 | Regional | Thyroid | 8070/3 | Squamous cell carcinoma | Undifferentiated | Not documented | Not documented | Negative | Negative | Positive | Negative | 29.8 | Negative | null | Resection | Yes | 11 | moderate_burden |
PATH-KEN-2025-00128 | Kenya | 2,025 | District | Bladder | 8260/3 | Papillary carcinoma | Well differentiated | Absent | Absent | Positive | Positive | Negative | Negative | 52.6 | Negative | null | Fine needle aspirate | Yes | 4 | moderate_burden |
PATH-ETH-2023-00129 | Ethiopia | 2,023 | District | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-UGA-2023-00130 | Uganda | 2,023 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Present | Absent | Positive | Not done | Negative | Negative | 81.2 | Negative | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2022-00131 | Tanzania | 2,022 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Negative | Positive | Not done | Positive | 34.7 | Not done | null | Core needle biopsy | No - inconclusive | 18 | moderate_burden |
PATH-TAN-2022-00132 | Tanzania | 2,022 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Not documented | Positive | Positive | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 25 | moderate_burden |
PATH-SOU-2022-00133 | South Africa | 2,022 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-ETH-2018-00134 | Ethiopia | 2,018 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | 36.0 | Positive | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-SOU-2020-00135 | South Africa | 2,020 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Present | Negative | Positive | Positive | Positive | Not done | Positive | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-SOU-2018-00136 | South Africa | 2,018 | National referral | Lung | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Not documented | Negative | Positive | Negative | Positive | 34.3 | Negative | null | Excisional biopsy | No - inconclusive | 19 | moderate_burden |
PATH-KEN-2022-00137 | Kenya | 2,022 | District | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Negative | Positive | Not done | 21.9 | Negative | null | Excisional biopsy | No - inconclusive | 21 | moderate_burden |
PATH-KEN-2019-00138 | Kenya | 2,019 | National referral | Thyroid | 8720/3 | Melanoma | Moderately differentiated | Present | Absent | Negative | Positive | Negative | Negative | 17.3 | Negative | null | Excisional biopsy | Yes | 17 | moderate_burden |
PATH-NIG-2024-00139 | Nigeria | 2,024 | National referral | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Positive | Negative | 82.9 | Positive | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-KEN-2024-00140 | Kenya | 2,024 | District | Thyroid | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 6 | moderate_burden |
PATH-TAN-2022-00141 | Tanzania | 2,022 | National referral | Liver | 8720/3 | Melanoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 65.2 | Negative | null | Resection | Yes | 16 | moderate_burden |
PATH-TAN-2019-00142 | Tanzania | 2,019 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Negative | Negative | 54.0 | Negative | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-GHA-2019-00143 | Ghana | 2,019 | District | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Negative | Positive | Not done | Not done | null | Resection | Yes | 19 | moderate_burden |
PATH-UGA-2021-00144 | Uganda | 2,021 | National referral | Thyroid | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Negative | Negative | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 18 | moderate_burden |
PATH-ETH-2021-00145 | Ethiopia | 2,021 | Regional | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Positive | Negative | 64.9 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-SOU-2019-00146 | South Africa | 2,019 | District | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Not done | Not done | Positive | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-KEN-2025-00147 | Kenya | 2,025 | District | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Present | Negative | Positive | Negative | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 4 | moderate_burden |
PATH-UGA-2025-00148 | Uganda | 2,025 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 82.4 | Negative | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-TAN-2021-00149 | Tanzania | 2,021 | Regional | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Positive | Not done | 52.2 | Not done | null | Excisional biopsy | No - inconclusive | 24 | moderate_burden |
PATH-UGA-2025-00150 | Uganda | 2,025 | National referral | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Positive | Negative | 40.1 | Not done | Triple negative | Resection | Yes | 7 | moderate_burden |
PATH-TAN-2019-00151 | Tanzania | 2,019 | National referral | Bladder | 8310/3 | Clear cell carcinoma | Poorly differentiated | Not documented | Not documented | Negative | Positive | Not done | Not done | 79.9 | Positive | null | Resection | Yes | 12 | moderate_burden |
PATH-NIG-2025-00152 | Nigeria | 2,025 | District | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-UGA-2021-00153 | Uganda | 2,021 | District | Ovary | 8310/3 | Clear cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Negative | 43.8 | Negative | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-GHA-2024-00154 | Ghana | 2,024 | National referral | Stomach | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Close | Negative | Positive | Negative | 64.8 | Not done | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-NIG-2025-00155 | Nigeria | 2,025 | National referral | Liver | 8720/3 | Melanoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Positive | Positive | 33.2 | Positive | null | Excisional biopsy | No - inconclusive | 21 | moderate_burden |
PATH-GHA-2018-00156 | Ghana | 2,018 | District | Liver | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Absent | Negative | Positive | Positive | Positive | Not done | Positive | null | Fine needle aspirate | Yes | 6 | moderate_burden |
PATH-UGA-2019-00157 | Uganda | 2,019 | National referral | Stomach | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Negative | Positive | 63.5 | Negative | null | Resection | Yes | 4 | moderate_burden |
PATH-SOU-2024-00158 | South Africa | 2,024 | District | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Negative | Positive | Positive | Positive | Not done | Positive | null | Excisional biopsy | No - inconclusive | 14 | moderate_burden |
PATH-GHA-2018-00159 | Ghana | 2,018 | District | Colorectal | 8720/3 | Melanoma | Poorly differentiated | Present | Absent | Close | Not done | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2019-00160 | Tanzania | 2,019 | Regional | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Negative | Negative | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 25 | moderate_burden |
PATH-KEN-2024-00161 | Kenya | 2,024 | National referral | Ovary | 8890/3 | Leiomyosarcoma | Moderately differentiated | Absent | Not documented | Close | Positive | Positive | Negative | 14.2 | Negative | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-TAN-2022-00162 | Tanzania | 2,022 | National referral | Thyroid | 8720/3 | Melanoma | Moderately differentiated | Not documented | Absent | Not applicable | Positive | Negative | Negative | 56.4 | Negative | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-TAN-2019-00163 | Tanzania | 2,019 | District | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Positive | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | No - suboptimal | 18 | moderate_burden |
PATH-NIG-2018-00164 | Nigeria | 2,018 | Regional | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Positive | Negative | 34.7 | Negative | null | Excisional biopsy | No - inconclusive | 23 | moderate_burden |
PATH-UGA-2018-00165 | Uganda | 2,018 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Negative | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-GHA-2022-00166 | Ghana | 2,022 | District | Cervix | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Negative | Positive | Positive | Not done | Not done | Not done | null | Excisional biopsy | No - inconclusive | 21 | moderate_burden |
PATH-NIG-2022-00167 | Nigeria | 2,022 | Regional | Lung | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 24.9 | Positive | null | Excisional biopsy | Yes | 17 | moderate_burden |
PATH-UGA-2023-00168 | Uganda | 2,023 | National referral | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Positive | Positive | Positive | Positive | 54.3 | Positive | Triple negative | Fine needle aspirate | Yes | 17 | moderate_burden |
PATH-SOU-2019-00169 | South Africa | 2,019 | National referral | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Not done | 75.3 | Negative | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-SOU-2019-00170 | South Africa | 2,019 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Well differentiated | Present | Absent | Negative | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-GHA-2022-00171 | Ghana | 2,022 | District | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Present | Not documented | Close | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-GHA-2023-00172 | Ghana | 2,023 | District | Colorectal | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Not documented | Positive | Positive | Positive | Not done | Not done | Not done | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-GHA-2022-00173 | Ghana | 2,022 | District | Stomach | 8070/3 | Squamous cell carcinoma | Well differentiated | Absent | Present | Close | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | No - inconclusive | 11 | moderate_burden |
PATH-GHA-2019-00174 | Ghana | 2,019 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Not done | Negative | 75.1 | Negative | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-SOU-2021-00175 | South Africa | 2,021 | District | Breast | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Negative | HER2+ | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-TAN-2023-00176 | Tanzania | 2,023 | District | Liver | 8510/3 | Medullary carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-GHA-2025-00177 | Ghana | 2,025 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Not done | null | Resection | Yes | 20 | moderate_burden |
PATH-ETH-2018-00178 | Ethiopia | 2,018 | National referral | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 58.9 | Negative | null | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-ETH-2018-00179 | Ethiopia | 2,018 | District | Thyroid | 8260/3 | Papillary carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Negative | Not done | Negative | null | Resection | Yes | 8 | moderate_burden |
PATH-ETH-2024-00180 | Ethiopia | 2,024 | District | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Positive | Not done | Negative | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-ETH-2024-00181 | Ethiopia | 2,024 | District | Colorectal | 8720/3 | Melanoma | Poorly differentiated | Present | Present | Negative | Positive | Negative | Not done | 66.9 | Negative | null | Fine needle aspirate | Yes | 5 | moderate_burden |
PATH-SOU-2022-00182 | South Africa | 2,022 | District | Prostate | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-ETH-2024-00183 | Ethiopia | 2,024 | District | Ovary | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 20 | moderate_burden |
PATH-SOU-2019-00184 | South Africa | 2,019 | National referral | Breast | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Not applicable | Positive | Negative | Negative | 80.3 | Positive | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-KEN-2018-00185 | Kenya | 2,018 | District | Thyroid | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Not documented | Close | Positive | Positive | Negative | 28.4 | Negative | null | Resection | Yes | 4 | moderate_burden |
PATH-ETH-2019-00186 | Ethiopia | 2,019 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Positive | Negative | Negative | Negative | 27.8 | Positive | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-ETH-2020-00187 | Ethiopia | 2,020 | Regional | Breast | 8500/3 | Ductal carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Negative | 69.4 | Negative | Luminal B | Resection | Yes | 15 | moderate_burden |
PATH-UGA-2022-00188 | Uganda | 2,022 | National referral | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Positive | Negative | Positive | Negative | 77.2 | Negative | null | Resection | Yes | 24 | moderate_burden |
PATH-NIG-2024-00189 | Nigeria | 2,024 | Regional | Breast | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Not done | Positive | 66.3 | Not done | Triple negative | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-ETH-2020-00190 | Ethiopia | 2,020 | Regional | Breast | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Absent | Negative | Not done | Positive | Negative | Not done | Positive | HER2+ | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-ETH-2020-00191 | Ethiopia | 2,020 | District | Thyroid | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Equivocal | Not done | Not done | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-GHA-2019-00192 | Ghana | 2,019 | National referral | Liver | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Absent | Positive | Negative | Negative | Negative | 37.7 | Negative | null | Excisional biopsy | Yes | 10 | moderate_burden |
PATH-TAN-2018-00193 | Tanzania | 2,018 | National referral | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Negative | Negative | 14.4 | Not done | null | Excisional biopsy | Yes | 20 | moderate_burden |
PATH-KEN-2022-00194 | Kenya | 2,022 | Regional | Ovary | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Not documented | Close | Negative | Positive | Negative | 45.3 | Positive | null | Excisional biopsy | Yes | 10 | moderate_burden |
PATH-TAN-2020-00195 | Tanzania | 2,020 | National referral | Ovary | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Close | Positive | Negative | Negative | Not done | Not done | null | Resection | Yes | 22 | moderate_burden |
PATH-TAN-2023-00196 | Tanzania | 2,023 | District | Liver | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Positive | Positive | Negative | Negative | 23.1 | Not done | null | Core needle biopsy | No - suboptimal | 15 | moderate_burden |
PATH-UGA-2025-00197 | Uganda | 2,025 | Regional | Bladder | 8510/3 | Medullary carcinoma | Moderately differentiated | Absent | Absent | Close | Negative | Positive | Not done | 54.3 | Negative | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-UGA-2022-00198 | Uganda | 2,022 | National referral | Prostate | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Close | Positive | Positive | Negative | 81.1 | Negative | null | Core needle biopsy | No - inconclusive | 6 | moderate_burden |
PATH-KEN-2024-00199 | Kenya | 2,024 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Not done | Not done | Positive | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-ETH-2023-00200 | Ethiopia | 2,023 | National referral | Breast | 8720/3 | Melanoma | Moderately differentiated | Absent | Not documented | Not applicable | Positive | Positive | Negative | 89.3 | Positive | null | Fine needle aspirate | No - inconclusive | 19 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.